Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children
Larotrectinib had marked and durable antitumor activity in patients with TRK fusion-positive cancer, regardless of the age of the patient or of the tumor type. (Funded by Loxo O...